Research ExplorerPublicationsHeyde syndrome: treat aortic valve disease to stop gastroint...

Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?

Standard

Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding? / Waldschmidt, Lara; Seiffert, Moritz.

In: EUR HEART J, Vol. 44, No. 33, 01.09.2023, p. 3178–3180.

Research output: SCORING: Contribution to journal › Editorial › Research

Harvard

Waldschmidt, L & Seiffert, M 2023, 'Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?', EUR HEART J, vol. 44, no. 33, pp. 3178–3180. https://doi.org/10.1093/eurheartj/ehad277

APA

Waldschmidt, L., & Seiffert, M. (2023). Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding? EUR HEART J, 44(33), 3178–3180. https://doi.org/10.1093/eurheartj/ehad277

Vancouver

Waldschmidt L, Seiffert M. Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding? EUR HEART J. 2023 Sep 1;44(33):3178–3180. https://doi.org/10.1093/eurheartj/ehad277

Bibtex

@article{e8bcfd48410d42dca0a6150f0224541c,
title = "Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?",
abstract = "Heyde syndrome is the association of aortic stenosis and gastrointestinal bleeding (GIB) from angiodysplasia, accompanied by acquired von Willebrand syndrome (aVWS) leading to decreased levels of high molecular weight multimers (HMWMs). The development of angiodysplasia in the gastrointestinal tract remains unclear. Mucosal ischaemia, high shear stress resulting from turbulence caused by the stenotic valve, and the presence of aVWS may be involved. Aortic valve replacement through surgical replacement (SAVR) or transcatheter aortic valve implantation (TAVI) leads to decreased shear stress and may resolve GIB through recovery of aVWS and potentially dissolving angiodysplasias.",
author = "Lara Waldschmidt and Moritz Seiffert",
year = "2023",
month = sep,
day = "1",
doi = "10.1093/eurheartj/ehad277",
language = "English",
volume = "44",
pages = "3178–3180",
journal = "EUR HEART J",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "33",

}

RIS

TY - JOUR

T1 - Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?

AU - Waldschmidt, Lara

AU - Seiffert, Moritz

PY - 2023/9/1

Y1 - 2023/9/1

N2 - Heyde syndrome is the association of aortic stenosis and gastrointestinal bleeding (GIB) from angiodysplasia, accompanied by acquired von Willebrand syndrome (aVWS) leading to decreased levels of high molecular weight multimers (HMWMs). The development of angiodysplasia in the gastrointestinal tract remains unclear. Mucosal ischaemia, high shear stress resulting from turbulence caused by the stenotic valve, and the presence of aVWS may be involved. Aortic valve replacement through surgical replacement (SAVR) or transcatheter aortic valve implantation (TAVI) leads to decreased shear stress and may resolve GIB through recovery of aVWS and potentially dissolving angiodysplasias.

AB - Heyde syndrome is the association of aortic stenosis and gastrointestinal bleeding (GIB) from angiodysplasia, accompanied by acquired von Willebrand syndrome (aVWS) leading to decreased levels of high molecular weight multimers (HMWMs). The development of angiodysplasia in the gastrointestinal tract remains unclear. Mucosal ischaemia, high shear stress resulting from turbulence caused by the stenotic valve, and the presence of aVWS may be involved. Aortic valve replacement through surgical replacement (SAVR) or transcatheter aortic valve implantation (TAVI) leads to decreased shear stress and may resolve GIB through recovery of aVWS and potentially dissolving angiodysplasias.

U2 - 10.1093/eurheartj/ehad277

DO - 10.1093/eurheartj/ehad277

M3 - Editorial

C2 - 37403478

VL - 44

SP - 3178

EP - 3180

JO - EUR HEART J

JF - EUR HEART J

SN - 0195-668X

IS - 33

ER -